Notal Vision Monitoring Center

04/01/2026

Congratulations to Majda Hadziahmetovic and the Duke Eye Center team on this important ForeseeHome catch.

Referred in early January 2026 with 20/20 vision, this patient’s wet conversion was diagnosed at the end of March 2026, with vision still at 20/20. Cases like this are an important reminder that change can happen between regularly scheduled visits, before a patient notices symptoms on their own.

The Notal Vision Monitoring Center is proud to partner with Duke Eye Center to support monitoring patients between visits.

03/27/2026

Jim Tsantles represents the Notal Vision Monitoring Center and our AMD remote monitoring services at the 12th Annual Duke Fellows Advanced Vitreous Surgery (fAVS) Course.

If you’re attending, make sure to stop by and say hi!

03/25/2026

Congratulations to Ryan Deasy, MD and the Virginia Eye Institute team on a ForeseeHome catch.

This patient was referred in October 2025 with 20/60 vision, and less than two months later, a ForeseeHome alert prompted evaluation and Dr. Deasey diagnosed wet AMD at 20/60-1.

Without monitoring between visits, this change may not have been identified until the patient’s next regularly scheduled appointment months later. Studies have shown that delays in treatment after wet AMD conversion are associated with worse visual outcomes.

The Notal Vision Monitoring Center is proud to partner with Virginia Eye Institute to support monitoring patients between visits.

03/23/2026

Today we celebrate optometrists for the meaningful role they play in patients’ lives and in the broader eye care journey.

As primary eye care doctors, optometrists help detect, manage, and monitor medical eye conditions, often serving as a trusted first point of care and an essential partner in protecting long-term vision.

Their expertise, attentiveness, and patient relationships make a real difference every day.

03/18/2026

A noteworthy ForeseeHome catch for Kathryn Hecker and the Hecker Eye Care Associates team.

After diligently testing for almost 6 years, this patient’s wet AMD conversion was caught with 20/50-3 vision. The same eye had previously generated a non-exudative alert—an earlier alert that did not result in conversion. Evidence shows these alerts may indicate a higher risk of future conversion and the need for more vigilant monitoring.

This is a great example of that long-term vigilance in action.

The Notal Vision Monitoring Center is proud to partner with Hecker Eye Care Associates to support monitoring patients between visits.

03/12/2026

Advanced at-home monitoring is becoming an important part of the conversation.

In a recent patient-education article, the American Academy of Ophthalmology highlights the role of at-home monitoring for people living with AMD. Home-based technologies can help extend care beyond the clinic. SCANLY Home OCT and ForeseeHome enable remote disease monitoring between scheduled visits for appropriate patients with AMD.

As monitoring technologies continue to advance, conversations like this help patients better understand how care can extend beyond the clinic visit.

Read the article 👉 https://notalvision.info/4bjpEcH

An FDA-approved at-home monitoring program for wet AMD may help make care easier and more personalized. Special devices let patients use OCT to check their eyes at home.

03/04/2026

Congratulations to Dr. Katia Taba and the Retina Group of Florida team for catching a patient’s wet conversion with ForeseeHome.

In this case, the patient was referred with 20/30 vision and generated a ForeseeHome alert just over a month later, leading to a wet AMD diagnosis at 20/50. Without home monitoring, the patient may not have been evaluated again until their next regularly scheduled appointment months later.

Timely evaluation and treatment initiation are widely recognized as important factors in visual outcomes for wet AMD. ForeseeHome monitoring between exams can help bring potential changes to clinical attention sooner.

The Notal Vision Monitoring Center is proud to partner with Retina Group of Florida to support ongoing AMD monitoring between visits.

02/27/2026

Are you at ? Make sure to stop by booth #246, say hi to Kenny, and learn more about how our remote monitoring solution can help your AMD patients maintain their good vision.

02/26/2026

Live from the 2026 meeting in San Diego.

Prof. Anat Loewenstein presented new data evaluating longitudinal Home OCT trajectories in neovascular AMD using the AI-based Notal OCT Analyzer (NOA).

The takeaway: AI-based trajectory analysis can accurately distinguish stable from changing patterns in Home OCT data, and personalized thresholds may enhance sensitivity in identifying change over time.

Congratulations to current president Julia Haller, MD and the organizing team for an excellent meeting that continues to spotlight the research shaping the future of retinal care.

02/25/2026

After over 5 years of monitoring with the ForeseeHome AMD Monitoring Program, this patient experienced a timely detection of wet in the left eye - caught at 20/50+2 vision - thanks to Dr. Melissa Summerfield and the North Iowa Eye Clinic team in Mason City, Iowa.

Early detection makes the difference in AMD management!

02/18/2026

After just 9 months of consistent monitoring with ForeseeHome, this patient’s progression to wet was detected early—while vision was still 20/25 – thanks to Joseph Anderson, OD, and team at Clarkson Eyecare in Lilburn, GA.

ForeseeHome serves as a vital safety net for AMD patients, helping detect early changes between office visits.

02/12/2026

What happens when AI meets longitudinal, at-home retinal imaging?

In a recent Retina Synthesis conversation, Dr. Carmen Puliafito and Dr. Ted Leng discussed research evaluating AI analysis of daily Home OCT imaging in neovascular AMD. The study showed strong agreement between AI outputs and expert human graders and highlighted the potential value of personalized change thresholds when assessing disease activity over time.

As retinal care continues to evolve, the integration of remote imaging, physician oversight, and AI-driven analysis may help clinicians stay more closely connected to what’s happening between regularly scheduled clinic assessments, while keeping treatment decisions firmly grounded in in-office evaluation.

Watch/listen to the full discussion:

We discuss a study that showed that an artificial intelligence powered system can detect clinically significant fluid as well as experienced observers using ...